γδ T Cells Predict Outcome in Zoledronate‐Treated Breast Cancer Patients

The biological mechanism underlying the antitumor role of zoledronate is unclear. The analysis in this letter illustrates the diagnostic and prognostic potential of a γδ T‐cell‐based blood test and implies a link between immune responsiveness and positive outcome with zoledronate therapy.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The oncologist (Dayton, Ohio) Ohio), 2013-08, Vol.18 (8), p.e22-e23
Hauptverfasser:	Welton, Joanne L., Martí, Salvador, Mahdi, Mohammed H., Boobier, Clare, Barrett‐Lee, Peter J., Eberl, Matthias
Format:	Artikel
Sprache:	eng
Schlagworte:	Breast Neoplasms - drug therapy Chemotherapy, Adjuvant Diphosphonates - administration & dosage Female Humans Imidazoles - administration & dosage Letters to the Editor
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The biological mechanism underlying the antitumor role of zoledronate is unclear. The analysis in this letter illustrates the diagnostic and prognostic potential of a γδ T‐cell‐based blood test and implies a link between immune responsiveness and positive outcome with zoledronate therapy.
ISSN:	1083-7159 1549-490X
DOI:	10.1634/theoncologist.2013-0097